Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) is -41.76% lower on its value in year-to-date trading and has touched a low of $8.04 and a high of $25.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ARCT stock was last observed hovering at around $13.62 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $13.78, the stock is 6.66% and 10.47% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 1.17% at the moment leaves the stock -12.94% off its SMA200. ARCT registered -18.80% loss for a year compared to 6-month loss of -16.89%. The firm has a 50-day simple moving average (SMA 50) of $12.474 and a 200-day simple moving average (SMA200) of $15.82885.
The stock witnessed a 6.00% gain in the last 1 month and extending the period to 3 months gives it a 35.10%, and is -4.37% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.01% over the week and 7.25% over the month.
Arcturus Therapeutics Holdings Inc (ARCT) has around 176 employees, a market worth around $373.72M and $131.27M in sales. Profit margin for the company is -51.95%. Distance from 52-week low is 71.39% and -46.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.00%).
The EPS is expected to shrink by -5.04% this year
218.0 institutions hold shares in Arcturus Therapeutics Holdings Inc (ARCT), with institutional investors hold 100.97% of the company’s shares. The shares outstanding are 27.12M, and float is at 24.83M with Short Float at 20.00%. Institutions hold 93.00% of the Float.
The top institutional shareholder in the company is FEDERATED HERMES, INC. with over 4.69 million shares valued at $114.3 million. The investor’s holdings represent 17.4067 of the ARCT Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $64.52 million to account for 9.8262 of the shares outstanding. The other top investors are ARK INVESTMENT MANAGEMENT LLC which holds 1.96 million shares representing 7.2866 and valued at over $47.85 million, while SUMITOMO MITSUI TRUST HOLDINGS, INC. holds 5.7962 of the shares totaling 1.56 million with a market value of $38.06 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Activity
The most recent transaction is an insider sale by Chivukula Pad, the company’s Chief Scientific Officer & COO. SEC filings show that Chivukula Pad sold 12,000 shares of the company’s common stock on Oct 15 ’24 at a price of $20.76 per share for a total of $0.25 million. Following the sale, the insider now owns 0.44 million shares.
